Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-11

Clinical Trial Update: Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effect of a single dose of nalmefene on BOLD fMRI signal in the ventral striatum during a reward task in non-treatment seeking indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nalmefene (nalmefene)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Alcohol Dependence | Phase 1 | Status: COMPLETED